Predicting future exacerbations in uncontrolled asthma: A discovery/validation approach using large-scale clinical
Lisa M Jurak1, Ian A Yang2, Jodie L Simpson3
1University of Queensland Frazer Institute, Woolloongabba, Australia.
The Journal of Allergy and Clinical Immunology
|March 6, 2025
Summary
Researchers identified a sputum protein signature linked to future asthma exacerbations. This discovery aids in finding new biomarkers and treatments for uncontrolled persistent asthma.
Area of Science:
- Pulmonology
- Proteomics
- Biomarker Discovery
Background:
- Asthma exacerbations significantly impact patient health and healthcare costs.
- Understanding the mechanisms behind recurrent exacerbations is crucial for effective management.
Purpose of the Study:
- To identify a protein signature in sputum that can predict future asthma exacerbations.
- To uncover potential biomarkers and therapeutic targets for uncontrolled persistent asthma.
Main Methods:
- Analyzed baseline sputum samples using high-throughput mass spectrometry.
- Developed a multivariate protein signature using sparse partial least squares analysis.
- Validated and quantified key proteins in an independent cohort.
Main Results:
- Identified 533 differentially abundant sputum proteins associated with future exacerbations.
- A 260-protein signature partially predicted exacerbations (AUC 0.95).
- A validated 9-protein signature predicted future exacerbations (AUC 0.77), highlighting inflammation and immune cell pathways.
Conclusions:
- This study presents the first sputum proteomic signature linked to future asthma exacerbations.
- The identified signature and pathways offer potential for novel biomarker and therapeutic target discovery.
- Findings are significant for advancing the treatment of uncontrolled persistent asthma.
Related Concept Videos
01:33Proteomics
7.1K
A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
7.1K
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
01:29Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
211
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
211
01:26Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
01:20Asthma: Pathogenesis and Management
314
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
314